Angeline Rose Babel, Ph.D., Partner


Angeline-Rose Babel, Ph.D., represents clients in the life sciences and biotechnological fields in all aspects of patent law, including patent prosecution, strategic management of patent portfolios, freedom-to-operate opinions, due diligence analysis and landscape analysis. Angeline is fascinated by advances in biotechnology and enjoys helping clients navigate the intellectual property landscape to help realize the potential of their new research and discoveries. She has extensive knowledge in preparing and prosecuting United States, Patent Cooperation Treaty (PCT) patent applications. Angeline works collaboratively with foreign counsel in prosecuting and procuring international patents.

Angeline's clients include global biotechnology companies, university technology transfer offices, start-up companies, and individuals. Her work for these clients encompasses a broad spectrum of technologies in biotechnology, pharmaceuticals and life sciences, including:

  • Biologics, including therapeutic antibodies and peptides
  • Vaccines and adjuvants, including DNA, RNA, and viral delivery mechanisms
  • Stem cells, methods of differentiation and use in treatment
  • Ex vivo modified cells and cell-based therapies including engineered stem cells and CAR-T cells
  • Artificial implants, including cartilage implants, skin grafts
  • Engineered proteins and nucleic acids, including mimetic peptides, siRNA, peptide inhibitors
  • Nanoparticles and drug delivery systems, including biological polymers
  • Medical diagnostics including proteomic and genomic assays, lateral flow technology
  • Small molecules and methods of use
  • Gene editing reagents, techniques, delivery methods
  • Research tools
  • Genetically altered cells and animals
  • Engineered proteins and nucleic acids
  • Method and use of the above technologies for treatment of disease

Angeline focuses her practice on client counseling regarding patent filing strategies and strategic portfolio building. Angeline received her Ph.D. from the University of Wisconsin-Madison in Cancer Biology. She worked in a microbiology laboratory studying the mechanism by which a retrovirus similar to HIV enters cells and using such viruses as reagents for targeted therapy.

Before entering the legal field, she also worked as a post-doctoral research fellow at the McArdle Laboratory for Cancer Research at the University of Wisconsin-Madison. Her research focused on molecular and cellular pathways activated during the early events of virus entry, the progression of viral infection and the development of cancer in Kaposi Sarcoma Virus.

Legal Services

Education and Honors

  • Chicago Kent College of Law at the Illinois Institute of Technology (J.D., cum laude, 2012)
    • CALI Excellence Award in Pharmaceutical Patent Law (2012)
  • University of Wisconsin (Ph.D., 2004)
    • Degree: Cancer Biology
  • Northwestern University (B.S., 1998)
    • Degree: Biomedical Engineering with a focus in Biotechnology

Bar Admissions

  • Illinois
  • Wisconsin

Court Admissions

  • U.S. Patent and Trademark Office, 2007

Professional and Civic Activities

  • Illinois State Bar Association (Member)
  • Chicago Bar Association (Member)
  • American Bar Association (Member)

Professional Recognition

  • The Best Lawyers in America® "Ones to Watch," Patent Law, 2022
Payment Portal

You are leaving the Quarles & Brady website and being directed to the bill presentment and paying service offered by a third party provider. If you do not wish to continue to the site, click Close or use the Back button on your web browser to return the Quarles & Brady website.